As of December 2019, there are 109 subsidiaries (6 domestically and 103 overseas), of which domestic listed companies are Samsung Biologics. It holds a 5.0% stake in Samsung Electronics and a 19.3% stake in Samsung Life Insurance.
Founded in 1963 as Cheil Industries, in September 2015, it merged with Samsung C&T to change its name to Samsung C&T.
The business sector is divided into the construction sector, the commercial sector (resource development and international trade), the fashion sector, the resort sector (everland, golf course, food distribution, etc.), and the biosimilar business.
2020/08/05 - [KOSPI] - The unfortunate sideways of Jeju Air that prolonged unpaid leave
2020/07/31 - [KOSPI] - Will Asiana Airlines in crisis sell off IDT?
2020/07/27 - [KOSPI] - The future of Doosan Solus with hydrogen fuel cell source technology
댓글 영역